Cav-1 in breast cancer-derived EXOs can act as a signaling molecule, regulating the formation of PMN in lung epithelial cells and inhibiting the PTEN/CCL2/VEGF-A signaling pathway in lung macrophages, thus promoting their M2 polarization and angiogenesis. This evidence concerns the gene CAV1 and breast carcinoma.